Download full report with analyst certification and important disclosures
Sep 6 2023, 07:15 IST/BST
Malin Corporation
H1 2023 results
- Sectors : Pharma and healthcare
- Companies : Malin Corporation
DAVY VIEW
Malin has published its H1 2023 results. The latest estimated intrinsic equity value is €6.49 per share, implying a c.48% premium to the share price of €4.40 per share. Malin may deploy up to €5m for a share buyback from the market. At the current share price, a buyback will result in an increase in the intrinsic equity value per share.
